Palvella Therapeutics approved to uplist to Nasdaq Global Market on May 13

PALVELLA THERAPEUTICS, INC.

Nasdaq approval for transfer from Capital Market to Global Market received May 11, 2026.
Effective at open of business on May 13, 2026; ticker PVLA unchanged.
Company will trade on the more prestigious Nasdaq Global tier.

item 8.01

Source: SEC EDGAR

accession 0001193125-26-220607

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.